Get started
Author

Camille Lenoir

Observed name: Lenoir, Camille
ORCID: 0000-0001-6506-8629
Observed ORCID: 0000-0001-6506-8629
OpenAlex ID: A5020492385
Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature
2021 · Camille Lenoir, Victoria Rollason, et al. · Frontiers in Pharmacology · 101
PDF
Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail
2020 · Camille Lenoir, Youssef Daali, et al. · Clinical Pharmacology & Therapeutics · 99
PDF
Impact of SARS‐CoV‐2 Infection (COVID‐19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail
2021 · Camille Lenoir, Jean Terrier, et al. · Clinical Pharmacology & Therapeutics · 61
PDF
Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review
2021 · Camille Lenoir, Frédérique Rodieux, et al. · Clinical Pharmacokinetics · 36
PDF
Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports
2020 · Silvia Fernandez, Camille Lenoir, et al. · Pharmacology Research & Perspectives · 35
PDF
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting
2022 · Camille Lenoir, Jean Terrier, et al. · Journal of Personalized Medicine · 29
PDF
Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?
2019 · Camille Lenoir, Myriam El Biali, et al. · International Journal of Clinical Pharmacy · 23
PDF
Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase
2021 · Silvia Fernandez, Camille Lenoir, et al. · Journal of Personalized Medicine · 21
PDF
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics
2021 · Camille Lenoir, Amine Niederer, et al. · CPT Pharmacometrics & Systems Pharmacology · 20
PDF
Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban
2025 · Frédéric Gaspar, Jean Terrier, et al. · British Journal of Clinical Pharmacology · 12
Apixaban and rivaroxaban's physiologically‐based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side
2023 · Jean Terrier, Frédéric Gaspar, et al. · CPT Pharmacometrics & Systems Pharmacology · 12
PDF
Outcomes of drug exposition during pregnancy: Analysis from a teratology information service
2020 · Camille Lenoir, Sabrina Boumaïza, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 11
Population pharmacokinetics of apixaban in a real‐life hospitalized population from the OptimAT study
2023 · Frédéric Gaspar, Jean Terrier, et al. · CPT Pharmacometrics & Systems Pharmacology · 6
PDF
Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient population
2024 · Yvonne S. Gloor, Médéric Mouterde, et al. · British Journal of Clinical Pharmacology · 1
PDF
CYP450 3A4 /5 Containment During SARS‐CoV ‐2 Infection
2022 · Jean Terrier, Camille Lenoir, et al. · Clinical Pharmacology & Therapeutics · 1
PDF
Works count: 16
Citation count: 468
H-index: 11
I10-index: 12
Year
Topic
Type